PT1054018E - Bibliotecas de fragmentos fab e métodos para a sua utilização - Google Patents
Bibliotecas de fragmentos fab e métodos para a sua utilização Download PDFInfo
- Publication number
- PT1054018E PT1054018E PT99201558T PT99201558T PT1054018E PT 1054018 E PT1054018 E PT 1054018E PT 99201558 T PT99201558 T PT 99201558T PT 99201558 T PT99201558 T PT 99201558T PT 1054018 E PT1054018 E PT 1054018E
- Authority
- PT
- Portugal
- Prior art keywords
- methods
- fab fragment
- fragment libraries
- fab
- libraries
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
- C07K16/3092—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated mucins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99201558A EP1054018B1 (en) | 1999-05-18 | 1999-05-18 | Fab fragment libraries and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1054018E true PT1054018E (pt) | 2009-02-16 |
Family
ID=8240210
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT91512335T PT2067788E (pt) | 1999-05-18 | 1999-05-18 | Bibliotecas de fragmentos fab e métodos para a sua utilização |
PT99201558T PT1054018E (pt) | 1999-05-18 | 1999-05-18 | Bibliotecas de fragmentos fab e métodos para a sua utilização |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT91512335T PT2067788E (pt) | 1999-05-18 | 1999-05-18 | Bibliotecas de fragmentos fab e métodos para a sua utilização |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP2067788B1 (pt) |
JP (3) | JP4741086B2 (pt) |
AT (1) | ATE421976T1 (pt) |
AU (1) | AU780145B2 (pt) |
CA (1) | CA2372582C (pt) |
DE (1) | DE69940364D1 (pt) |
DK (2) | DK2067788T3 (pt) |
ES (2) | ES2549440T3 (pt) |
HK (1) | HK1134303A1 (pt) |
PT (2) | PT2067788E (pt) |
WO (1) | WO2000070023A1 (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60237704D1 (de) | 2001-10-16 | 2010-10-28 | Government Of The Us Secretary | Neutralisierende antikörper gegen hiv mit breiter kreuzreaktion, die mit hilfe von env-cd4-co-rezeptorkomplexen selektiert werden |
CA2484930A1 (en) * | 2002-05-06 | 2003-11-13 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries |
WO2003095492A1 (en) | 2002-05-06 | 2003-11-20 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
ES2368733T3 (es) | 2002-07-18 | 2011-11-21 | Merus B.V. | Producción recombinante de mezclas de anticuerpos. |
USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
US20040072262A1 (en) * | 2002-10-11 | 2004-04-15 | Montero-Julian Felix A. | Methods and systems for detecting MHC class I binding peptides |
CN1777673B (zh) | 2003-03-07 | 2010-04-28 | 新英格兰医学中心医院有限公司 | IgA1沉积疾病的治疗 |
US7157562B1 (en) * | 2003-04-14 | 2007-01-02 | The United States Of America As Represented By The Secretary Of The Army | Bioprocess for the production of recombinant anti-botulinum toxin antibody |
US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
CA2527694C (en) | 2003-05-30 | 2015-07-14 | Hendricus Renerus Jacobus Mattheus Hoogenboom | Fab library for the preparation of anti vegf and anti rabies virus fabs |
US20070160994A1 (en) * | 2003-12-15 | 2007-07-12 | Institut Pasteur | Repertoire determination of a lymphocyte b population |
AU2005207003C1 (en) | 2004-01-20 | 2013-06-13 | Humanigen, Inc. | Antibody specificity transfer using minimal essential binding determinants |
EP1737971B1 (en) | 2004-01-20 | 2017-08-16 | Merus N.V. | Mixtures of binding proteins |
ES2387809T3 (es) | 2004-03-19 | 2012-10-02 | Imclone Llc | Anticuerpo frente al receptor del factor de crecimiento epidérmico humano |
MY146381A (en) * | 2004-12-22 | 2012-08-15 | Amgen Inc | Compositions and methods relating relating to anti-igf-1 receptor antibodies |
EP1707628B1 (en) * | 2005-03-30 | 2009-11-11 | Sekisui Chemical Co., Ltd. | Methods for producing recombinant polyclonal immunoglobulins |
EP2069558B1 (en) * | 2006-10-02 | 2013-05-01 | Sea Lane Biotechnologies,llc. | Design and construction of diverse synthetic peptide and polypeptide libraries |
CN101126760B (zh) * | 2007-01-17 | 2011-11-16 | 江苏省人民医院 | 全人源抗卵泡刺激素β单链抗体筛选方法及其用途 |
EP2894222B8 (en) * | 2010-02-19 | 2019-04-24 | Japan Science and Technology Agency | Human abzyme |
WO2012142662A1 (en) | 2011-04-21 | 2012-10-26 | Garvan Institute Of Medical Research | Modified variable domain molecules and methods for producing and using them b |
DK2761006T3 (en) | 2011-09-28 | 2017-03-27 | Zera Intein Protein Solutions S L | Cleft inteins and uses thereof |
MX360109B (es) | 2012-04-20 | 2018-10-23 | Merus Nv | Metodos y medios para la produccion de moleculas de tipo ig. |
US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
EP2883883A1 (en) | 2013-12-16 | 2015-06-17 | Cardio3 Biosciences S.A. | Therapeutic targets and agents useful in treating ischemia reperfusion injury |
MX2017012679A (es) | 2015-04-06 | 2018-02-09 | Subdomain Llc | Polipeptidos que contienen dominios de union de novo y usos de los mismos. |
PT3440208T (pt) | 2016-04-06 | 2020-12-04 | Zumutor Biologics Inc | Vetores para clonagem e expressão de proteínas, métodos e suas aplicações |
CA3028002A1 (en) | 2016-06-27 | 2018-01-04 | Juno Therapeutics, Inc. | Method of identifying peptide epitopes, molecules that bind such epitopes and related uses |
MA45491A (fr) | 2016-06-27 | 2019-05-01 | Juno Therapeutics Inc | Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés |
WO2018192974A1 (en) | 2017-04-18 | 2018-10-25 | Université Libre de Bruxelles | Biomarkers and targets for proliferative diseases |
US11851679B2 (en) | 2017-11-01 | 2023-12-26 | Juno Therapeutics, Inc. | Method of assessing activity of recombinant antigen receptors |
JP7285267B2 (ja) | 2017-11-14 | 2023-06-01 | アーセルクス インコーポレイテッド | Dドメイン含有ポリペプチドおよびその使用 |
CN112384527B (zh) | 2018-03-23 | 2023-06-27 | 布鲁塞尔自由大学 | Wnt信号传递激动剂分子 |
JP7332691B2 (ja) | 2018-07-08 | 2023-08-23 | スペシフィカ インコーポレイティド | 抗体の開発可能性が最大化された抗体ライブラリー |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US4518584A (en) | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
US4518564A (en) | 1983-10-03 | 1985-05-21 | Jeneric Industries, Inc. | Gallium and silver free, palladium based dental alloys for porcelain-fused-to-metal restorations |
US4798885A (en) | 1986-02-07 | 1989-01-17 | Genentech, Inc. | Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
WO1990014443A1 (en) | 1989-05-16 | 1990-11-29 | Huse William D | Co-expression of heteromeric receptors |
ATE139574T1 (de) | 1989-11-06 | 1996-07-15 | Cell Genesys Inc | Herstellung von proteinen mittels homologer rekombination |
US5126323A (en) | 1989-11-16 | 1992-06-30 | Genetics Institute, Inc. | Homogeneous purified k-fgf and compositions containing the same |
US5272071A (en) | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
DE4005633A1 (de) | 1990-02-22 | 1991-08-29 | Schuetz Werke Gmbh Co Kg | Palettenbehaelter |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
DE69233750D1 (de) * | 1991-04-10 | 2009-01-02 | Scripps Research Inst | Bibliotheken heterodimerer Rezeptoren mittels Phagemiden |
NZ245015A (en) | 1991-11-05 | 1995-12-21 | Transkaryotic Therapies Inc | Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production |
DE69331278T2 (de) | 1992-09-04 | 2002-07-18 | Scripps Research Inst | Phagemiden die einen oberflächenrezeptor und ein heterologes oberflächenprotein co-exprimieren |
NZ267842A (en) | 1993-05-28 | 1997-09-22 | Baylor College Medicine | Apparatus for measuring molecular mass (by mass spectrometry) in which the sample is ionised on the sample holder and desorbed therefrom by laser pulses |
ATE326234T1 (de) | 1993-08-26 | 2006-06-15 | Genetics Inst Llc | Menschliche knochen-morphogenetische proteine zur verwendung bei neuronaler regeneration |
ES2255059T3 (es) | 1993-12-07 | 2006-06-16 | Genetics Institute, Llc | Bmp-12, bmp-13 y composiciones suyas inductoras de tendon. |
-
1999
- 1999-05-18 DK DK09151233.5T patent/DK2067788T3/da active
- 1999-05-18 ES ES09151233.5T patent/ES2549440T3/es not_active Expired - Lifetime
- 1999-05-18 PT PT91512335T patent/PT2067788E/pt unknown
- 1999-05-18 ES ES99201558T patent/ES2321568T3/es not_active Expired - Lifetime
- 1999-05-18 AT AT99201558T patent/ATE421976T1/de active
- 1999-05-18 PT PT99201558T patent/PT1054018E/pt unknown
- 1999-05-18 DE DE69940364T patent/DE69940364D1/de not_active Expired - Lifetime
- 1999-05-18 DK DK99201558T patent/DK1054018T3/da active
- 1999-05-18 EP EP09151233.5A patent/EP2067788B1/en not_active Expired - Lifetime
- 1999-05-18 EP EP99201558A patent/EP1054018B1/en not_active Expired - Lifetime
-
2000
- 2000-05-18 AU AU51422/00A patent/AU780145B2/en not_active Expired
- 2000-05-18 WO PCT/US2000/013682 patent/WO2000070023A1/en active IP Right Grant
- 2000-05-18 CA CA2372582A patent/CA2372582C/en not_active Expired - Lifetime
- 2000-05-18 JP JP2000618429A patent/JP4741086B2/ja not_active Expired - Lifetime
-
2009
- 2009-12-10 HK HK09111645.7A patent/HK1134303A1/xx not_active IP Right Cessation
-
2010
- 2010-08-09 JP JP2010178912A patent/JP5159841B2/ja not_active Expired - Lifetime
-
2012
- 2012-11-01 JP JP2012241643A patent/JP2013078315A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2067788B1 (en) | 2015-07-22 |
ATE421976T1 (de) | 2009-02-15 |
ES2321568T3 (es) | 2009-06-08 |
JP5159841B2 (ja) | 2013-03-13 |
ES2549440T3 (es) | 2015-10-28 |
EP1054018A1 (en) | 2000-11-22 |
DK2067788T3 (da) | 2015-10-19 |
DK1054018T3 (da) | 2009-05-18 |
WO2000070023A9 (en) | 2002-01-17 |
JP2013078315A (ja) | 2013-05-02 |
AU5142200A (en) | 2000-12-05 |
JP4741086B2 (ja) | 2011-08-03 |
JP2010273689A (ja) | 2010-12-09 |
HK1134303A1 (en) | 2010-04-23 |
EP1054018B1 (en) | 2009-01-28 |
DE69940364D1 (de) | 2009-03-19 |
AU780145B2 (en) | 2005-03-03 |
EP2067788A3 (en) | 2010-04-21 |
WO2000070023A1 (en) | 2000-11-23 |
PT2067788E (pt) | 2015-10-29 |
CA2372582A1 (en) | 2000-11-23 |
JP2002543830A (ja) | 2002-12-24 |
EP2067788A2 (en) | 2009-06-10 |
CA2372582C (en) | 2013-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1134303A1 (en) | Fab fragment libraries and methods for their use fab | |
NZ334226A (en) | Humanized immunoglobulin reactive with alpha 4 beta 7 integrin | |
HK1076128A1 (en) | Humanized collagen antibodies and related methods | |
DK0933082T3 (da) | Fremgangsmåde til manipulation af celledifferentiering | |
UA89017C2 (uk) | ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b | |
TW200516083A (en) | Methods for making dual specificity antibodies | |
AR085874A2 (es) | Un anticuerpo monoclonal o un fragmento del mismo que se une a un antigeno | |
ATE255906T1 (de) | Antikörper gegen cd40 | |
MX347883B (es) | Anticuerpo monoclonal ds6, antigeno ca6 asociado con tumor, y metodos de uso de los mismos. | |
NZ594466A (en) | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | |
RS80704A (en) | ANTI- av?6.ANTIBODIES | |
IN2009KN02655A (pt) | ||
NO2006008I1 (no) | Natalizumab, anti alfa-4 integrin humanized monoclonal antibody | |
WO1997046589A3 (en) | Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods | |
ES2173130T3 (es) | Metodo de fijacion de material al peptido beta-amiloide. | |
HK1016194A1 (en) | Methods for identifying compounds that bind to a target | |
WO2002074251A3 (en) | Monoclonal antibody therapy for pancreas cancer | |
WO2003072727A3 (en) | EGFRvIII SPECIFIC MONOCLONAL ANTIBODY AND EGFRvIII RIBOZYMES AND USE TO DETECT, TREAT OR PREVENT EGFRvIII ASSOCIATED CANCER | |
ATE312622T1 (de) | Verwendung von anti-hbp antikörper zur inhibierung der freisetzung von bradykinin | |
NO20004251D0 (no) | Humaniserte anti-CEA monoklonale antistoffer med høy affinitet | |
WO2002094194A3 (en) | Compositions and methods for inhibiting metastasis | |
IL139571A0 (en) | A humanized antibody that binds to verotoxin, methods for the production thereof and pharmaceutical compositions containing the same | |
WO2004039401A3 (en) | Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis | |
FR2710068B1 (fr) | Dérivés de nucléosides, procédés de fabrication de ces dérivés de nucléosides et anticorps polyclonaux et monoclonaux spécifiques de ces dérivés. | |
HUP0003029A2 (hu) | Ankrod specifikus monoklonális antitestek, antitestfragmentumok, keverékeik és alkalmazásuk |